INSMED develops and sells medicines for serious lung diseases and other conditions, based in Bridgewater, New Jersey. It last closed at $141.33 on Nov 20, down 2.17% on the day. The next earnings report for INSM is expected around Thu, Feb 18, 2027. For the quarter ended Sep 2026, INSM reported EPS of -$0.46 on revenue of $524.4M, with revenue up 268.4% from a year ago. Over its last 8 reports the stock moved an average of 12.6% the session after earnings. Over the last 12 months INSM insiders bought $0 of stock on the open market and sold $148.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is INSM in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold INSM.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on INSMStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
INSM · as of the Nov 20 close · updated each morning
Turning up, overbought
The stock is 19% above its 20 day and 21% above its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 73), overbought. The nearest support is the Pivot S1 at $138.21, and the nearest resistance the Pivot at $144.11.
Short trendBullish
Long trendNeutral
MomentumStrong
StretchOverbought
VolatilityHigh, 4.8%/day
Key levels
$212.7552 week high+50.5%
$147.22Pivot R1+4.2%
$144.11Pivot+2.0%
$141.33Last close
$138.21Pivot S1−2.2%
$122.56200 day average−13.3%
$122.21Swing low (Aug 14)−13.5%
$115.1120 day average−18.6%
$114.28100 day average−19.1%
$111.0950 day average−21.4%
$90.3952 week low−36.0%
Indicators
RSI (14)
73.20
Overbought above 70
Overbought
MACD
7.42
Above its signal line
Bullish
Stochastic
82.9
Near the top of its range
Overbought
ADX (14)
35.2
Trending up
Williams %R
-18.3
Oversold below −80, overbought above −20
Overbought
CCI (20)
216.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+23.5%
Change over 10 sessions
Bullish
ATR (14)
$6.79
Typical daily range, 4.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 9.7%/day
Key levels
$212.7552 week high+50.5%
$147.22Pivot R1+4.2%
$144.11Pivot+2.0%
$141.33Last close
$138.21Pivot S1−2.2%
$122.56200 day average−13.3%
$122.21Swing low (Aug 14)−13.5%
$115.1120 day average−18.6%
$114.28100 day average−19.1%
$111.0950 day average−21.4%
$90.3952 week low−36.0%
Indicators
RSI (14)
60.44
Strong, overbought above 70
Neutral
MACD
-1.46
Above its signal line
Bullish
Stochastic
66.6
Middle of its range
Neutral
ADX (14)
15.8
No clear trend
Williams %R
-15.1
Oversold below −80, overbought above −20
Overbought
CCI (20)
150.7
Oversold below −100, overbought above 100
Overbought
Rate of change
+9.2%
Change over 10 sessions
Bullish
ATR (14)
$13.71
Typical daily range, 9.7% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for INSM
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how INSM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow INSM usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for INSMHow many large options trades hit INSM, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in INSM in the last 90 days.
From SEC Form 4 filings by INSM's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INSM is in one of them and how their past INSM trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About INSMED
INSMED is a biopharmaceutical company based in Bridgewater, New Jersey. It develops and sells medicines for serious diseases, with a focus on lung conditions. Its two marketed products are ARIKAYCE, an inhaled treatment for lung disease caused by MAC, and BRINSUPRI, an oral tablet for bronchiectasis, a chronic lung disease. Its other programs target pulmonary hypertension, an immune condition called hidradenitis suppurativa, and neurological diseases such as Duchenne muscular dystrophy and ALS. Its patients are people living with these conditions.